Bruno Julianne

CIK 00020196452 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002019645

Recent Transactions

22 trades

Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2026-03-23+37,313→ 37,313 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Series C Preferred Stock
2026-02-09−129→ 0 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Common Stock
2026-02-09+129,000→ 137,032 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-21$41.23/sh−1,714→ 10,544 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-20−3,750→ 11,250 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-20+3,750→ 12,258 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-03-14+36,666→ 36,666 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-14+27,500→ 27,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-12$43.32/sh−190→ 8,508 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-11−435→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-11+435→ 8,698 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-11$42.42/sh−1,198→ 8,263 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-10+2,399→ 9,461 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-10−2,399→ 4,796 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-19$52.80/sh−333→ 7,062 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-02-18−650→ 650 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-02-18+650→ 7,395 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-06-21$56.09/sh−3,366→ 6,745 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-06-20−7,000→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-06-20+7,000→ 10,111 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-05-23+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O DAMORA THERAPEUTICS, INC., 221 CRESCENT ST, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov